Pathways, including OX40-OX40L and CD28-CD80/CD86, have been found to play an important role in skin disorders and to be involved at different stages of CD8 T cell activation/differentiation but as yet have not been linked to MC-CD8 T cell interactions. Here, CD86 is linked to skin disorder.